We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App




Image: DBS sampling is simple, inexpensive and can be self-collected by the patient at home, using a simple finger prick (Photo courtesy of University of Birmingham)

Dried Blood Spot Sampling Offers Inexpensive Way to Widen Access to COVID-19 Antibody Testing

Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, according to a new study by immunology experts at the University of Birmingham (Birmingham, UK). More...
28 Sep 2020
Image: Blood-Based Test That Accurately Identifies Viral Infection Before Symptoms Develop Could Help in Early Identification of SARS-CoV-2 (Photo courtesy of Duke University Health System)

Blood-Based Test That Accurately Identifies Viral Infection Before Symptoms Develop Could Help in Early Identification of SARS-CoV-2

Newly-identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease offer a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases, such as COVID-19. More...
28 Sep 2020
Image: New, Portable COVID-19 Saliva-Based Testing Device to Deliver Results in as Little as 20 Minutes (Photo courtesy of Charlie Leight/ASU Now)

New, Portable COVID-19 Saliva-Based Testing Device to Deliver Results in as Little as 20 Minutes

Researchers at Arizona State University (ASU Tempe, AZ, USA) are developing a new, portable saliva-based testing device that will deliver results in as little as 20 minutes. More...
28 Sep 2020
Image: GeneXpert System (Photo courtesy of Cepheid)

Cepheid Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV Granted FDA Emergency Use Authorization

Cepheid (Sunnyvale, CA, USA) has been issued an emergency use authorization (EUA) by the US Food and Drug Administration for its four-in-one combination test for SARS-CoV-2, Flu A, Flu B and RSV. More...
28 Sep 2020
Image: Scanning electron microscope (SEM) image showing SARS-CoV-2 (round gold objects) emerging from the surface of laboratory cultured cells (Photo courtesy of [U.S.] National Institute of Allergy and Infectious Diseases)

One-Step CRISPR-Based Assay Could Streamline COVID-19 Testing

An advanced CRISPR-based diagnostic test for COVID-19 produces results in 30 to 60 minutes, with accuracy similar to the standard CDC (Centers for Disease Control and Prevention) RT- qPCR test now in routine use. More...
28 Sep 2020
Illustration

FDA Authorizes First Nanopore Sequencing-Based Test for SARS-CoV-2

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to the Clear Dx SARS-CoV-2 novel descriptive diagnostic from Clear Labs (San Carlos, CA, USA), making it the first nanopore sequencing-based test for SARS-CoV-2 to receive EUA. More...
25 Sep 2020
Illustration

New ABC Test for Influenza A, Influenza B, and COVID-19 to Be Launched in First Week of October

A new ABC Test (Influenza A/Influenza B/COVID-19) is anticipated to be ready for launch to US CLIA laboratory customers the first week of October 2020. More...
25 Sep 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.